Category: Uncategorized

Jarlath Keating Joins as President of Solvias Group USA

Solvias Expands U.S. Capabilities as RTP Center Becomes cGMP-Ready

Solvias to Speak at Festival of Biologics 2025 on Building Robust CMC Assays for Biologic Therapies

Solvias to Speak at ASGCT 2025 Highlighting Safer Gene Therapy Development

Solvias Earns Strong First Assessment from EcoVadis

Center of Excellence for Biologics and Cell & Gene Therapy opens in Research Triangle Park (RTP), North Carolina.

Cergentis is Now Solvias NL

Elemental Analysis Lab Receives “Green” Certification from My Green Lab

Solvias to Build Biologics and Cell & Gene Therapy Testing Center in Research Triangle Park

Global provider continues to expand analytical service capabilities for life science companies developing advanced treatments for cancer and rare diseases KAISERAUGST, Switzerland – May 6, 2024 – Solvias announced today that it is expanding its global network of laboratory testing centers with a new biotech site in Research Triangle Park, N.C. It is the company’s latest […]

Solvias to Perform Release Testing on World’s First CRISPR-based Gene-Editing Therapy

Global Provider Signs Long-Term Agreement with Vertex Pharmaceuticals for CASGEVY™ Kaiseraugst, Switzerland – January 23, 2024 – Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, announced today that it will perform analytical release testing services on the world’s first CRISPR/Cas9 genome-edited cell therapy. The company has signed a long-term agreement with Vertex Pharmaceuticals for CASGEVY™ (exagamglogene […]